Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manfred Gerlach

Showing results (131-140 of 149) with videos related to

Pageof 15
Sort By:
Pharmaceutics|June 27, 2024
Serum Concentration-Dose Relationship and Modulation Factors in Children and Adolescents Treated with FluvoxamineRegina Taurines, Gesa Kunkel, Stefanie Fekete, et al.
Frontiers in Psychiatry|November 3, 2022
Systematic review and meta-analysis on the therapeutic reference range for escitalopram: Blood concentrations, clinical effects and serotonin transporter occupancyLuzie Eichentopf, Christoph Hiemke, Andreas Conca, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|March 26, 2019
Guidelines for the standardized collection of blood-based biomarkers in psychiatry: Steps for laboratory validity - a consensus of the Biomarkers Task Force from the WFSBPAna C Andreazza, Isabelle Laksono, Brisa S Fernandes, et al.
Plos One|July 15, 2010
A53T-alpha-synuclein overexpression impairs dopamine signaling and striatal synaptic plasticity in old miceAlexander Kurz, Kay L Double, Isabel Lastres-Becker, et al.
Clinical Pharmacokinetics|May 13, 2020
Pipamperone Population Pharmacokinetics Related to Effectiveness and Side Effects in Children and AdolescentsSanne M Kloosterboer, Karin M Egberts, Brenda C M de Winter, et al.
Brain : a Journal of Neurology|October 2, 2010
Stiff person syndrome-associated autoantibodies to amphiphysin mediate reduced GABAergic inhibitionChristian Geis, Andreas Weishaupt, Stefan Hallermann, et al.
Attention Deficit and Hyperactivity Disorders|March 25, 2011
Evaluation of the efficacy and effectiveness of a structured disorder tailored psychotherapy in ADHD in adults: study protocol of a randomized controlled multicentre trialAlexandra Philipsen, Erika Graf, Ludger Tebartz van Elst, et al.
European Eating Disorders Review : the Journal of the Eating Disorders Association|August 18, 2023
Therapeutic drug monitoring in adolescents with anorexia nervosa for safe treatment with adjunct olanzapineAndreas Karwautz, Michael Zeiler, Julia Schwarzenberg, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|October 27, 2016
Consensus paper of the WFSBP Task Force on Biological Markers: Criteria for biomarkers and endophenotypes of schizophrenia, part III: Molecular mechanismsAndrea Schmitt, Daniel Martins-de-Souza, Schahram Akbarian, et al.
Child and Adolescent Psychiatry and Mental Health|October 14, 2025
Off-label drug use in children and adolescents treated with antidepressants and antipsychotics: results from a prospective multicenter trialRegina Taurines, Manfred Gerlach, Christoph U Correll, et al.
Pageof 15

Showing results (131-140 of 149) with videos related to

Sort By:
Pageof 15
Pharmaceutics|June 27, 2024
Serum Concentration-Dose Relationship and Modulation Factors in Children and Adolescents Treated with FluvoxamineRegina Taurines, Gesa Kunkel, Stefanie Fekete, et al.
Frontiers in Psychiatry|November 3, 2022
Systematic review and meta-analysis on the therapeutic reference range for escitalopram: Blood concentrations, clinical effects and serotonin transporter occupancyLuzie Eichentopf, Christoph Hiemke, Andreas Conca, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|March 26, 2019
Guidelines for the standardized collection of blood-based biomarkers in psychiatry: Steps for laboratory validity - a consensus of the Biomarkers Task Force from the WFSBPAna C Andreazza, Isabelle Laksono, Brisa S Fernandes, et al.
Plos One|July 15, 2010
A53T-alpha-synuclein overexpression impairs dopamine signaling and striatal synaptic plasticity in old miceAlexander Kurz, Kay L Double, Isabel Lastres-Becker, et al.
Clinical Pharmacokinetics|May 13, 2020
Pipamperone Population Pharmacokinetics Related to Effectiveness and Side Effects in Children and AdolescentsSanne M Kloosterboer, Karin M Egberts, Brenda C M de Winter, et al.
Brain : a Journal of Neurology|October 2, 2010
Stiff person syndrome-associated autoantibodies to amphiphysin mediate reduced GABAergic inhibitionChristian Geis, Andreas Weishaupt, Stefan Hallermann, et al.
Attention Deficit and Hyperactivity Disorders|March 25, 2011
Evaluation of the efficacy and effectiveness of a structured disorder tailored psychotherapy in ADHD in adults: study protocol of a randomized controlled multicentre trialAlexandra Philipsen, Erika Graf, Ludger Tebartz van Elst, et al.
European Eating Disorders Review : the Journal of the Eating Disorders Association|August 18, 2023
Therapeutic drug monitoring in adolescents with anorexia nervosa for safe treatment with adjunct olanzapineAndreas Karwautz, Michael Zeiler, Julia Schwarzenberg, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|October 27, 2016
Consensus paper of the WFSBP Task Force on Biological Markers: Criteria for biomarkers and endophenotypes of schizophrenia, part III: Molecular mechanismsAndrea Schmitt, Daniel Martins-de-Souza, Schahram Akbarian, et al.
Child and Adolescent Psychiatry and Mental Health|October 14, 2025
Off-label drug use in children and adolescents treated with antidepressants and antipsychotics: results from a prospective multicenter trialRegina Taurines, Manfred Gerlach, Christoph U Correll, et al.
Pageof 15